Gene Query: CDKN2AIP

Dataset Description Geneva Score
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 70.97
R430: A potent inbibitor of DNA and RNA viruses 54.77
Transcriptome analysis in Neobractatin treated cells 53.36
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 45.03
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 43.54
Cajal bodies are linked to genome conformation 35.22
Cajal bodies are linked to genome conformation [RNA-Seq] 35.22
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 35.13
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 34.32
IDH3a KO RNA-seq 32.81
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 30.51
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 30.51
RNA sequencing of matched nephrectomy samples [RNA-seq] 27.17
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 27.17
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 26.26
Tracking of dCas9-methyltransferase footprints 24.33
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 23.83
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 22.65
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 22.21
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 21.89
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 19.51
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 19.09
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 18.19
SETBP1-WT and SETBP1-G870S epigenetic landscapes 18.19
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 18.13
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 16.93
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 15.59
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 15.59
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 14.94
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 14.86
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 14.79
Effect of drugs on transcriptomic profiles 14.79
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 14.08
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 14.08
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 13.47
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 12.65
Gene expression analysis of the impact of TDP-43 knockout in human cells. 12.51
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 12.4
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 12.39
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 12.39
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 12.29
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 12.26
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 12.26
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 11.99
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 11.63
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 11.6
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 11.5
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 11.5
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 11.32
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 11.09
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 10.93
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 10.79
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 10.69
Gene expression profiling of leukemia cells following asparagine depletion 10.09
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 10.07
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 10.07
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 9.98
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.9
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 9.77
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 9.72
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 9.72
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 9.55
Genome-wide analysis of the Integrator complex (HTS) 9.41
Genome-wide analysis of the Integrator complex 9.41
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 9.16
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 9.14
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 9.07
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 9.07
Identification of transcription start sites for human A549 cell line using ReCappable-seq 9.05
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 8.95
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 8.81
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 8.74
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 8.63
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.62
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 8.54
RNA-Seq from early time points in the kidney differentiation protocol 8.53
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 8.46
RNA-seq in transgenic cells 8.43
RNA-seq of tumor cells following angiopellosis extravasation 8.38
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 8.38
ETV7 and interferon response 8.38
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 8.34
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.22
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 8.19
Seletive inhibition of CDK9 in DLBCL cell lines 8.17
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 8.17
Endometrial transcriptome and PGR cistrome in cycling fertile women 8.16
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 8.16
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.13
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.13
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 7.98
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 7.98
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.89
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.89
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 7.82
Effect of BB608 on Gene Expression in HNSCC Cell Line 7.65
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.56
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 7.54
U1 snRNP telescripting regulates size-function stratified human genome 7.52
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 7.44
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 7.4
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 7.4
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.38
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 7.31
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 7.28
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.17
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 7.15
Gene expression in PANC1 cells treated with Rakicidin 7.13
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 6.99
Glioblastoma stem cells infected by ZIKA virus 6.91
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 6.81
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 6.74
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 6.71
ADAR1-editing of cellular and measles virus-derived duplex RNA 6.7
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 6.7
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 6.67
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 6.66
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.64
ARID1A regulates condensin II distribution and chromosomal partition 6.56
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 6.56
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 6.53
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 6.53
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.51
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.5
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.45
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 6.32
Noncoding regions are the main source of targetable tumor-specific antigens 6.21
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.2
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 6.18
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.15
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.15
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 6.14
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 6.14
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 6.11
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 5.8
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 5.77
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.73
RNAseq Study in CC-671 Treated Cal-51 Cells 5.67
Effect of mitochondria deficiency on senescence-associated gene expression 5.66
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 5.65
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 5.63
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 5.62
Gene expression alterations of pancreatic intraepithlial neoplasia 5.58
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.56
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 5.54
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.52
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.46
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 5.45
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.42
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 5.32
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.27
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 5.23
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 5.22
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.17
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 5.08
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 5.04
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 5.03
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.01
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.01
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 5.01
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 5.01
The bromodomain protein BRD4 regulates splicing during heat shock 4.99
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 4.91
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.87
Capturing the Interactome of Newly Transcribed RNA 4.87
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 4.83
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.77
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.76
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 4.73
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.73
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.72
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 4.69
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 4.66
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 4.65
Altering cancer transcriptomes using epigenomic inhibitors 4.65
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 4.65
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.63
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.63
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.59
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 4.59
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 4.58
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 4.58
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.53
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.51
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.49
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.49
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 4.49
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 4.48
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.48
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.46
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.39
UBC9 knockdown in bladder cancer T24 cell lines 4.39
Effect of ILF3 on translation during homeostasis and the antiviral response 4.36
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 4.35
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 4.34
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.33
Effect of disulfiram treatment on pediatric high grade glioma 4.27
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.26
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 4.22
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 4.22
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 4.2
SRSF2 mutations impair hematopoiesis and alter exon recognition 4.17
Short and Long RNA sequencing of human mature erythrocytes 4.16
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 4.16
Transcriptomic and gene ontology profiling of the human corneal cell types 4.13
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.09
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 4.04
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.98
RNA-seq data from human lymphoma cell lines 3.95
ChIP-seq and RNA-seq from human lymphoma cell lines 3.95
MARCKS and lnc-MARCKS act as inflammation regulators 3.94
Primary human trophoblast from term placenta 3.87
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.86
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.85
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.84
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.83
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.83
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.83
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 3.79
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.74
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.74
Regulation of poly(A) tail and translation during the somatic cell cycle 3.7
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.7
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.7
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.69
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 3.68
Cleavage Factor Im as a key regulator of 3’ UTR length 3.64
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.63
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 3.61
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.6
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.6
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 3.59
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.58
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.58
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 3.57
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.57
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.57
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.56
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 3.53
Developmental stage specific chromosome architecture in human erythroid cells 3.53
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.49
NHLRC1 re-expression in cancer cells 3.47
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.45
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 3.44
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 3.42
Identification of global regulators of T-helper cell lineage specification 3.42
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.42
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.42
SLAM-seq for K562 endogenous mRNA decay 3.4
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.39
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.33
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 3.28
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 3.27
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 3.26
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 3.26
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 3.26
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.24
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 3.22
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.21
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.18
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 3.18
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 3.15
RNA-seq analyisis of PUM2 knockout cells 3.13
Impact on erythroid progenitor type on erythroid differntiation 3.12
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 3.08
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.07
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.07
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.07
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.06
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.02
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.97
Sensing self and nonself circular RNAs 2.96
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 2.95
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.95
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.95
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.94
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.94
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.93
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.93
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.93
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.92
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 2.92
Human HAP1 cells before and after nutrient deprivation 2.92
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 2.9
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.9
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 2.83
RNA-Sequencing of HepG2 cells treated with TGFBeta 2.82
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 2.76
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.76
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 2.75
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 2.74
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.74
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 2.73
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.65
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 2.64
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 2.64
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.6
Lysine benzoylation is a novel histone mark [RNA-seq] 2.52
Lysine benzoylation is a novel histone mark 2.52
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.46
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.45
RNA seq comparison between scrambled and shGRP78 cells 2.44
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.44
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.44
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 2.4
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.39
Tpl-2 small molecule project 2.35
Tpl-2 and MEK small molecule inhibitors 2.35
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.35
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.32
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 2.27
LIN28A Over-expression RNAseq 2.26
Human ovarian granulosa cell transcriptome 2.26
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.23
Controlling for gene expression changes in transcription factor protein networks. 2.22
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 2.22
Leucegene: ALL sequencing 2.21
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.2
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.18
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 2.18
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.16
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 2.15
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 2.15
Modulation of nonsense-mediated decay by rapamycin 2.13
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 2.11
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.09
Zika virus directly infects human peripheral neurons and induces cell death 2.07
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.05
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.02
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.0
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.0
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.0
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.98
snRNAs as regulators of alternative splicing 1.98
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 1.97
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.96
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.96
Transcriptome Profiling of Human Primary Monocytes 1.95
RNA splicing alteration on glioblastoma and normal neural stem cells 1.95
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.93
RNA-seq analysis of differentiating human erythroblasts 1.92
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.88
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.87
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.86
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.84
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 1.83
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.83
Transcriptomic profiling of human peripheral blood-derived mast cells 1.83
Gene expressions of H9s in different culture systems 1.82
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 1.82
Gene expression analysis in response to hypoxic pathway inhibition 1.81
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.81
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.8
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 1.8
NKX2.2 1.8
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 1.8
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.79
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.78
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.76
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.76
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.73
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.73
The role of CFTR in islet function 1.71
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.71
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.7
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.66
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.65
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.65
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.58
Reprogrammed myeloid cell transcriptomes in NSCLC 1.57
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.56
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.56
Effects of rFVIIIFc on human macrophages 1.55
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 1.51
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.5
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.49
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.43
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.42
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.41
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.4
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.4
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.37
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 1.37
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.36
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.36
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.34
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 1.34
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.34
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.34
Human Treg NaCl stimulation 1.33
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.27
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.23
MAIT cell RNA sequencing 1.22
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.22
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.21
Effect of PRDM11 depletion in U2932 cells 1.2
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.2
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.19
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.16
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 1.16
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.13
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.13
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.13
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.08
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.07
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.06
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 1.06
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.05
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.05
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.04
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.03
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.01
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.01
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.98
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.98
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 0.96
RNAseq of T-ALL upon long non coding rna purturbation 0.95
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.94
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.94
mRNA recovered upon RNF219 IP. [RNA-IP] 0.94
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.93
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.91
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.91
Single-cell analysis of adult human ovary using 10X genomics 0.88
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.88
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.87
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.85
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.84
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.84
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.83
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.82
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.82
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.82
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.81
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.81
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 0.8
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.79
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.76
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.76
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.74
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.74
Analyses of T-ALL (COG study) 0.74
RNA sequencing of T-ALL (COG study) 0.74
Functional significance of the HIV-1 Tat signature amino acid residues 0.7
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.67
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.67
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.61
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.6
Single-Cell Genotyping of Transcriptomes 0.59
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.59
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.56
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.56
RNA-seq of cancer cell lines treated with T-025 0.55
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.54
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.53
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.53
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.52
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.51
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.5
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.49
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.49
Discovering human diabetes-risk gene function with genetics and physiological assays 0.49
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.48
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.42
Disruption of GRIN2B impairs differentiation in human neurons 0.38
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.38
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.38
RNA-seq of cells with TET1 knockout 0.37
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.35
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.35
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.34
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.31
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.3
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.29
Total RNA-Seq data from leukemic patients with complex structural variants 0.29
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.28
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.26
Transcriptome-wide modulation of splicing by the exon junction complex 0.26
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.25
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.24
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.23
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.23
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.23
quanTIseq: quantifying immune contexture of human tumors 0.21
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.21
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.16
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.13
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.13
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.11
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.09
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.08
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.05
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.05
Leucegene: AML sequencing (part 6) 0.05
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.04
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.04
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.04
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.03
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation